• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Editor’s Choice

Editor's Choice

Synthetic Bacterial Memory Circuits Enable Microbial Diagnostics for Sensing Biomolecules in the Gut

July 4, 2019 Lindsay Brownell

Millions of people take capsules of probiotics with the goal of improving their digestion, but what if those bacteria were also able to detect diseases in the gut and indicate when something is awry? New […]

Editor's Choice

Gut Microbes Eat Parkinson’s Medication

June 17, 2019 Caitlin McDermott-Murphy

The first time Vayu Maini Rekdal manipulated microbes, he made a decent sourdough bread. At the time, young Maini Rekdal, and most people who head to the kitchen to whip up a salad dressing, pop […]

Editor's Choice

Webinar: Improving Ulcerative Colitis Symptoms with Probiotics

June 12, 2019 Microbiome Times

  Speakers: Thomas Tompkins, R&D Manager & Ghania Sohail, Clinical Research Associate – Rosell Institute for Microbiome & Probiotics by Lallemand

Editor's Choice

Investing in the Microbiome: A discussion between Isabelle de Cremoux & Malcolm Kendall

June 5, 2019 Microbiome Times
Editor's Choice

Five-minute Microbiome Science Roundup: May 2019

June 5, 2019 Kristina Campbell

This month’s roundup includes a study on a unique gut-microbiota-modulating dietary intervention (vegetables rich in inulin-type fructans), and a study on how gut microbiota might predict Crohn’s disease recurrence after ileal resection. Furthermore, several different […]

Editor's Choice

Gut check: Yale researchers describe role of bacteria in drug response

June 4, 2019 Microbiome Times

Yale researchers identified human gut microbes that metabolize over 150 therapeutic drugs, a finding that highlights the role bacteria play in determining how well individuals respond to medications, they report June 3 in the journal […]

Editor's Choice

New Findings from Human Microbiome Project Reveal how Microbiome is Disrupted During IBD

May 30, 2019 Microbiome Times

A new study led by researchers from Harvard T.H. Chan School of Public Health and the Broad Institute of MIT and Harvard is the first to have observed the complex set of chemical and molecular […]

Editor's Choice

Biotech Focus: Live Lactobacilli as a Solution to Improve Skin Health

May 28, 2019 Microbiome Times

Topical application of beneficial lactobacilli and potentially other ‘live biotherapeutic products’ (LBPs) show great potential as an alternative strategy to tackle skin care problems related to disturbance of the skin microbiome, providing alternatives to the […]

Editor's Choice

IMM-ETG: A New European Initiative for Intestinal Microbiome Medicinal Products

May 21, 2019 Alice Rouanet

Caelus Health, EnteroBiotix, Ferring Pharmaceuticals, and MaaT Pharma, in coordination with the Pharmabiotic Research Institute (PRI), are working in collaboration within the ‘Intestinal Microbiome-based Medicines European Task Group (IMM-ETG)’ to propose a harmonised, pan-European, regulatory […]

Editor's Choice

Modulating the Preterm Gut Microbiota: An Interview with Dr Lindsay Hall

May 9, 2019 Microbiome Times

Dr Lindsay Hall of the Quadram Institute talks to us about the preterm infant gut microbiota and its modulation.

Editor's Choice

Pharmabiotics 2019 Wrap Up: The Latest in Microbiotic Medicinal Products

May 6, 2019 Nina Vinot

This 5th Pharmabiotics Conference Edition, hosted by the Pharmabiotic Research Institute, took place Mid-March in Paris and peaked as the most successful to date, with over 190 delegates attending over the 2-day event. As in […]

Posts navigation

« 1 … 10 11 12 … 14 »

Download the MT Forum Agenda:

Sign Up to Free Newsletter

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
    February 11, 2026
  • Immunity as a Lifestyle Priority
    January 30, 2026
  • Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
    November 17, 2025
  • The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
    November 12, 2025
  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
sign up

Sign up to the Microbiome Times newsletter